"Il Centro Emofilia e Trombosi Angelo Bianchi Bonomi, diretto dalla Professoressa Flora Peyvandi, fornisce un ampio ventaglio di prestazioni, per fare diagnosi e per intervenire direttamente su emofilia e malattie della coagulazione, emorragiche e trombotiche. Si rivolge a persone di tutte le età: neonati, bambini, adulti e anziani. Il Centro assiste ogni anno in regime ambulatoriale, di day hospital e ricovero ospedaliero, più di 3000 pazienti affetti da malattie emorragiche e trombotiche. Il Centro si distingue per un'attività di ricerca applicata alla clinica."

During the past decade, IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi" conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are "Hemophilia A" (5 trials), "Severe Hemophilia A" (2 trials), "Haemophilia A" (1 trials), "Moderate Hemophilia A" (1 trials) and "Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials). Many other conditions were trialed in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" in a lesser frequency.

Most popular intervention types in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (6 trials), "Bypassing Agents" (1 trials), "FVIII Replacement" (1 trials), "Factor VIII (FVIII)" (1 trials) and "Standard of Care for Haemophilia A" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"" are 8 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi"". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Ca' Granda Ospedale Maggiore Policlinico; Centro Emofilia e Trombosi "Angelo Bianchi e Bonomi", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".